STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary...
Transcript of STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary...
![Page 1: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/1.jpg)
Tom Wurdinger
Cancer Center Amsterdam
VU University Medical School
STOPhersentumoren Symposium
![Page 2: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/2.jpg)
Preclinical brain tumor models
![Page 3: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/3.jpg)
Primary glioma cells expressing Firefly
luciferase and fluorescent mCherry
Firefly luciferase / mCherry
Preclinical glioma models
![Page 4: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/4.jpg)
Preclinical glioma models
![Page 5: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/5.jpg)
WEE1 inhibitor: PD0166285
![Page 6: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/6.jpg)
Control AZD1775 IR IR + AZD1775
AZD1775
Phase I/II trial
NCT01849146
WEE1 inhibitor: AZD1775 (NCT01849146)
![Page 7: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/7.jpg)
MPS1 inhibitor: preclinical drug discovery
![Page 8: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/8.jpg)
U87R1 tumor volumeU87 tumor volume U87 survival U87R1 survival
TMZ sensitizers: Hydroxyurea
2000-compound FDA drug screen
Hydroxyurea
Phase I/II trial
scheduled
![Page 9: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/9.jpg)
CTRL
TMZ
RO
TMZ+RO
Day 6 Day 10 Day 13 Day 16 RLU
Click # LH2013061013502510 Jun 2013 13:50:38Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 247 m1,2,3Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmicClick # LH20130614165739
14 Jun 2013 16:57:52Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 247 m1,2,3Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013061710200617 Jun 2013 10:20:19Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 247 m1,2,3Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013062016081620 Jun 2013 16:08:27Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 259 m1,2,3Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013061013340410 Jun 2013 13:34:18Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 246 m1,2,3Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmicClick # LH20130614163904
14 Jun 2013 16:39:17Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 246 m1,2,3Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013061710040917 Jun 2013 10:04:22Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 246 m1,2,3Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013062016243520 Jun 2013 16:24:48Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 260 m1,2,3Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013061013260210 Jun 2013 13:26:16Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 245 m4,5,6Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013061416301514 Jun 2013 16:30:29Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 245 m4,5,6Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013061709551817 Jun 2013 09:55:31Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 245 m4,5Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013061909360319 Jun 2013 09:36:16Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 257 m3,4Experiment: Hs683 R1 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013061013071910 Jun 2013 13:07:32Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 244 m4,5,6Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013061416113814 Jun 2013 16:11:51Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 244 m4,5,6Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013061709390317 Jun 2013 09:39:17Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 244 m5,6Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013062016001920 Jun 2013 16:00:32Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 258 m5,6Experiment: Hs683 R1 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Click # LH2013061710200617 Jun 2013 10:20:19Bin:M (4), FOV12.5, f1, 1mFilter: OpenCamera: IVIS 11215, DW434
Series: cage 247 m1,2,3Experiment: Hs683 FMLabel: Comment: Analysis Comment:
5
6
7
8
910
5
2
3
4
5
6
7
8
910
6
Color BarMin = 50000Max = 1e+06
bkg subflat-fieldedcosmic
Phase I/II trial
ongoing
NCT01119599
TMZ sensitizer: RO4929097 (NCT01119599)
![Page 10: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/10.jpg)
TAKE HOME MESSAGE: NEW THERAPIES ON THE HORIZON
Hydroxyurea
Phase I/II trial
Scheduled
RO4929097
Phase I/II trial
NCT01119599
MPS1i
Preclinical study
Ongoing
AZD1775
Phase I/II trial
NCT01849146
Rindopepimut NCT01480479
Valganciclovir (Valcyte; FDA approved)
Bevacizumab (Avastin; FDA approved)
![Page 11: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/11.jpg)
BRAIN TUMOR CENTER AMSTERDAM
Neuro-oncology Research Group
VU University medical center | Cancer Center Amsterdam
![Page 12: STOPhersentumoren Symposium · STOPhersentumoren Symposium. Preclinical brain tumor models. Primary glioma cells expressing Firefly luciferase and fluorescent mCherry Firefly luciferase](https://reader033.fdocuments.us/reader033/viewer/2022050201/5f54aa3d099a1413ae3dfaf6/html5/thumbnails/12.jpg)
Tom Wurdinger
Cancer Center Amsterdam
VU University Medical School
STOPhersentumoren Symposium